A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM)
暂无分享，去创建一个
R. Vij | P. Hari | S. Iida | J. Kaufman | F. Davies | S. Harrison | D. Madduri | M. Minnema | M. Raab | P. Kapoor | R. Lesley | S. Ailawadhi | A. Spencer | S. Lentzsch | Anjali Sharma | V. V. Upreti | A. Minella | J. Larsen | Hans C. Lee | Zhao Yang | S. Harrison